MétaCan
Menu
Back to cohort
Record W4413856562 · doi:10.1093/noajnl/vdaf166.024

19 SURVIVAL AND RECURRENCE OUTCOMES FOR PRIMARY MENINGEAL MELANOCYTIC NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM IN A MULTICENTER COHORT

2025· article· en· W4413856562 on OpenAlexaboutno aff
Kira Tosefsky, Alexander D. Rebchuk, Ryan Gensler, M. Mullarkey, N Alarifi, Eduardo M. Suero, Chetan Bettegowda, Andrew Gao, Gelareh Zadeh, Stephen Yip, Serge Makarenko

Bibliographic record

VenueNeuro-Oncology Advances · 2025
Typearticle
Languageen
FieldMedicine
TopicBrain Metastases and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCohortMulticenter studyCentral nervous systemOverall survivalCohort studyOncologyInternal medicine

Abstract

fetched live from OpenAlex

Abstract BACKGROUND Primary melanocytic neoplasms of the central nervous system (PMN-CNS) are rare lesions of variable aggressiveness originating from leptomeningeal melanocytes. They present as either circumscribed or diffuse lesions within the CNS. Given the limited number of reported cases, survival and recurrence outcomes are poorly understood. METHODS A retrospective chart review of all local adult (≥18 years) cases of PMN-CNS across four centres in Canada, the United States and Germany (1993-present). RESULTS Forty-eight cases were identified, with median age at diagnosis of 58 years (IQR: 38-68), 52% female. Tumour locations included cerebrum (30, 63%), spine (10, 21%), multifocal (6, 13%) and diffuse (1, 2%). Twelve (25%) tumours had confirmed GNAQ/GNA11, five (10%) NRAS, two (4%) BRAF V600E and one (2%) BRAF V600K mutations. BAP1 deletions were identified in two (4%) cases. Operative outcomes were: gross total resection (22, 46%), subtotal resection (18, 38%) and biopsy-only (5, 10%). Surgery was followed by adjuvant radiotherapy in 31 (65%) cases and adjuvant chemotherapy and/or immunotherapy in 26 (54%) cases, with various combinations of nivolumab/ipilimumab, pembrolizumab, temozolomide, dabrafenib, trametinib, encorafenib and binimetinib. Radiographic recurrence was observed in 24 (50%) cases at a median of 14 (95% CI: 11, —) months postoperatively. Median overall survival time was 26 months (95% CI: 18, —). CONCLUSIONS There is substantial heterogeneity in the molecular and clinical characteristics of PMN-CNS. As the largest multicenter cohort study of this tumour class, our findings will help to define the natural history of the disease, assist in prognostication and guide treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.021
Threshold uncertainty score0.368

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.305
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology AdvancesSame topicBrain Metastases and TreatmentFrench-language works237,207